Figure 3From: Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gagpeptides in liposomes and ISCOMs with in-built adjuvanticityHIV plaque neutralization by serial dilutions of antibody. Data were normalized as a percentage of the mean plaque count in 12 replicate control wells which was 10.4 and 13.1 for V3-gp41 and gp41 peptides respectively.Back to article page